Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cells (iPS cells) are a promising source for a cell-based therapy to treat Parkinson's disease (PD), in which midbrain dopaminergic neurons progressively degenerate. However, long-term analysis of human iPS cell-derived dopaminergic neurons in primate PD models has never been performed to our knowledge. Here we show that human iPS cell-derived dopaminergic progenitor cells survived and functioned as midbrain dopaminergic neurons in a primate model of PD (Macaca fascicularis) treated with the neurotoxin MPTP. Score-based and video-recording analyses revealed an increase in spontaneous movement of the monkeys after transplantation. Histological studies showed that the mature dopaminergic neurons extended dense neurites into the host striatum; this effect was consistent regardless of whether the cells were derived from patients with PD or from healthy individuals. Cells sorted by the floor plate marker CORIN did not form any tumours in the brains for at least two years. Finally, magnetic resonance imaging and positron emission tomography were used to monitor the survival, expansion and function of the grafted cells as well as the immune response in the host brain. Thus, this preclinical study using a primate model indicates that human iPS cell-derived dopaminergic progenitors are clinically applicable for the treatment of patients with PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Morizane et al. and Kikuchi et al. both showed that an improvement of engraftment and reduced immune reaction were observed using MHC matching of iPSC-derived dopaminergic neurons in unlesioned non-human primates [98,99].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [99]
In the citing paper
“A comprehensive study of human iPSC-derived dopamine neuron progenitor cells expressing specific markers of the neural floor plate (CORIN+; FOXA2+; TUJ1+; PAX6−) and transplanted into a monkey model of Parkinson’s disease showed stronger evidence of behavioural benefits, of cellular integration of mature dopamine neurons within the putamen, and of extension of their dense neurites into the host st”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [82]
In the citing paper
“Most of the transplanted cells expressed FOXA2 and a third expressed tyrosine hydroxylase consistent with mature functional dopamine neurons.”
From How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) · cites this paper as [82]
Citations
Cites
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Fast robust automated brain extraction
Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496
Zhang, Y., Brady, M., & Smith, S. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906424 · Cited by 6,982
A global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 6,872
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,907
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
Cited by
Items 601–700 of 705
Current Treatments for Parkinson's Disease
Saitoh, Y. (2019) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.56.180
Research Advances in Exosome and Their MicroRNA for Parkinson’s Disease
白, 家. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.95098 · Cited by 1
From Zero to Neuro-Reprogramming: Innovations in Translational Neuroregenerative Medicine
Galuta, A., & Tsai, E. C. (2019) · University of Ottawa Journal of Medicine · doi:10.18192/uojm.v9i1.4163 · Cited by 1
“progression of neurodegeneration and restore homeostatic neuronal functioning (18,23,58).”
BackgroundDisease modeling and drug discovery utilizing iPS cells
Toguchida, J. (2019) · Tenri Medical Bulletin · doi:10.12936/tenrikiyo.22-001
In Vitro Differentiation of T Cells: From Nonhuman Primate-Induced Pluripotent Stem Cells
Iriguchi, S., & Kaneko, S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9728-2_11
Desgres, M., & Menasché, P. (2019) · médecine/sciences · doi:10.1051/medsci/2019155 · Cited by 1
“capables d’améliorer les déficits moteurs dans des modèles pré-cliniques de la maladie y compris chez le primate non humain [3].”
BackgroundDopaminergic Neuron-Related Stem Cells
Wang, C., & Ding, Y. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-33923-4_10
Human Pluripotent Stem Cells and Neural Regeneration
Zhang, X. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-33923-4_9
Neurotransplantation: the Time Has Come?
Illarioshkin, S. N. (2019) · Human Physiology · doi:10.1134/s0362119719080048
Non-human primate iPS cells for cell replacement therapies and human cardiovascular disease modeling
Rodríguez-Polo, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7757
iPS Cell and Renal Regenerative Medicine
Araoka, T., & Osafune, K. (2020) · Springer eBooks · doi:10.1007/978-981-15-1108-0_24
Cell transplantation therapy for Parkinson's disease
Chmielarz, P., Konovalova, J., & Domanskyi, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00036-3 · Cited by 1
Yin, S., Li, W., Yang, G., Cheng, Y., Yi, Q., Fan, S., Ma, Q., & Zeng, F. (2020) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2020-0003
Shi, Y., van Rhijn, J.-R., Bormann, M., Mossink, B., Frega, M., Recaioglu, H., Hakobjan, M., Gunnewiek, T. M. K., Schoenmaker, C., Palmer, E. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.359224
Wu, J., Chai, T., Zhang, H., Huang, Y., Perry, S. W., Li, Y., Duan, J., Tan, X., Hu, X., Liu, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-136570/v1
“The sample sizes (n=6/every 128 group) were chosen based on the data of previous NHP studies [17, 18], and 129 our previous works on behavior and biochemical measures in M.”
MethodiPSCs and cell therapy for Parkinson’s disease
Schweitzer, J. S., Song, B., & Kim, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00005-x
Sorlí, A. R. (2020) · Gredos (University of Salamanca) · doi:10.14201/gredos.145461
Deficiency of miR-29 a/b1 Leads to Premature Aging and Dopaminergic Neuroprotection in MicePreprint
Bai, X., Wang, J., Zhang, X., Tang, Y., Han, L., Fang, R., Liu, Z., Dong, H., Li, Q., Ge, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-495801/v1
Bergmann, T., Liu, Y., Mogus, L., Lee, J., Pfisterer, U., Handfield, L.-F., Asenjo-Martinez, A., Vargas, I. L., Seemann, S. E., Lee, J. T. H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/738443
Li, H., Wei, J., Pan, L., Zhang, Y., Guo, L., Qin, D., Yin, Y., Hu, X., & Wang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-470057/v1
Investigating the pathophysiology of anorexia nervosa using induced pluripotent stem cells
Maussion, G., Demirova, I., Gorwood, P. A. P. M., & Ramoz, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00005-3 · Cited by 1
Autologous Transplantation for Parkinson's Disease Patients: Feasibility and Challenge
Zhang, Q., Wang, Y., Wang, Y., Liu, H., Sun, H., Wang, Z., Shi, C., Yang, J., & Xu, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00712-w
Stem cells in regenerative processes: Induced pluripotent stem cells
Osafune, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00030-5
KOSAWADA, T., Kitsunai, T., Feng, Z., & Goto, K. (2021) · Technologies · doi:10.3390/technologies9040083
Galiano, J. M. M., & Delgado‐Rodríguez, M. (2013) · PubMed · Cited by 3
Wenker, S. D., Gradaschi, V., Ferrari, C. C., Farías, M. I., Garcia, C. I., Beauquis, J., Zeng, X., & Pitossi, F. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.11.475933
Borchert, T. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8874
Torres-Ortega, P. V. (2021) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/63294
Anatomy of the basal nuclei of Alouatta belzebul
Sabec-Pereira, D. K., de Melo, F. R., de Melo, F. C. S. A., Pereira, K. F., & Vulcani, V. A. S. (2022) · Ciência Animal Brasileira · doi:10.1590/1809-6891v22e-70584
Past・Present・Future on Parkinson's Disease Therapeutics
Hattori, N. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.762
Sontheimer, H. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821228-8.00005-6
Role of stem cell in medical care and treatment
Khan, F., Sahu, K., Pathan, S., & Gupta, B. K. (2022) · GSC Advanced Research and Reviews · doi:10.30574/gscarr.2022.11.3.0161
“The first attempt for using human ESC cells to treat PD was via the generation of dopaminergic-like neurons, later human iPSCs was proposed as an alternative to overcome ESCs controversies [23].”
Attempts to reconstruct Neural Circuits by Cell Transplantation
Takahashi, J. B. (2022) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.31.573
Self-citationImproving three-dimensional human pluripotent cell culture efficiency via surface molecule coating
Li, Q., Pan, Y., Han, L., Yang, Y., Wu, X., & Lei, Y. (2022) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2022.1031395 · Cited by 1
What is the potential of stem cells as a therapy for Parkinson's disease?Preprint
Khalil, S. A. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/t8u2f
Induced Pluripotent Stem Cells: Progress toward Clinical Translation from Bench to Bedside
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_40
Liu, C., Lin, A., Xing, Q., Zhang, D., Meng, W., Wu, R., Shi, H., Huang, W., Huang, X., Qin, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.15.539796
“To fulfill this perspective, extensive studies have been carried out by transplanting human NPCs in intact [1-4] or damaged brain [5-10], in the adult, neonatal [11] or fetal [12] rodents, as well as in the non-human primate disease models [13, 14].”
BackgroundExperimental Neurotransplantation for Cerebellar Ataxias
Cendelín, J., Buffo, A., Hirai, H., Magrassi, L., Manto, M. U., Mitoma, H., & Sherrard, R. M. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_18
Iwasaki, M., Drummond, N. J., McNay, D. E. G., Canham, M. A., Tikhomirov, D., Arafa, D., Lelos, M. J., Morizane, A., & Kunath, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2996413/v1
Self-citation3) iPS Cell-based Therapy for Parkinson's Disease
TAKAHASHI, J. C. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.1752
Self-citationCurrent progress of stem cell-based therapy
Li, Z. (2023) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2023.050904
Selbstreproduktion: Zellteilung, Krebs, Stammzellen und Epigenetik
Plattner, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-66740-8_12
Fehse, B., Schickl, H., Bartfeld, S., & Zenke, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-67908-1 · Cited by 3
Recent advances in computational modeling
Pinky, P., Neha, N., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13222-3.00006-x
Liang, L., Tian, Y., Feng, L., Wang, C., Feng, G., Stacey, G. N., Shyh‐Chang, N., Wu, J., Hu, B., Li, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20486794
Li, Y., Xu, J., Jiang, C., Chen, Z., Chen, Y., Ying, M., Wang, A., Ma, C., Wang, C., Guo, Y., et al. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.02.05
Jiang, T., Huang, J., Xu, B., Ge, Z., Li, Y., Wei, L., Yu, L., & Li, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122816
Advanced treatments for autoimmune diseases
Singh, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19085-8.00009-6
Possible Roles of Epigenetics in Stem Cell Therapy for Parkinson’s Disease
Krubaa, P. (2024) · SBV Journal of Basic Clinical and Applied Health Science · doi:10.4103/sbvj.sbvj_13_24
Mishra, R., & Bowman, A. B. (2024) · Advances in neurotoxicology · doi:10.1016/bs.ant.2024.07.001
History of cellular grafting for central nervous system repair—A clinical perspective
Lindvall, O. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00011-3
Stem cell therapy as a novel concept to combat CNS disorders
Kumar, R., Mahajan, S., Gupta, U., Madan, J., Godugu, C., Guru, S. K., Singh, P. K., Parvatikar, P., & Maji, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00009-1
Stammzellen: Einsatz in der Nephrologie
Novikoff, S., Câmara, N. O. S., & Semedo, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-65236-3_3
Roslan, F. F., Yu, Y., Wang, M., Yusof, N. A. N. M., Ooi, G., Then, K. L., Then, K. Y., Cheong, S., Patar, M. N. A. A., & Tan, J. J. (2024) · Cellular Reprogramming · doi:10.1089/cell.2024.0073
“Dopaminergic neuron differentiation was performed following the protocol established by Kikuchi et al. (2017), with an optimized concentration of 0.75 l m CHIR99021 (Tocris Bioscience, Bristol, UK).”
InfluentialStem cell therapy in neurodegenerative disorders
Hefnawy, M. T., Shaheen, N., Elsamman, K., Husain, M. A., Mostafa, N., Khalil, M., Amro, Y., & Meshref, M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00032-4
Stem cell for PD: Technical considerations
Ibrahim, S. S., Elmligy, E., & Tharwat, E. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00008-6
Stem Cell Therapy in Parkinson's DiseasePreprint
Mafi, J. (2025) · doi:10.31219/osf.io/6dzgh_v1
Central Nervous System Affections
Gugjoo, M. B. (2025) · Wiley eBooks · doi:10.1002/9781394253289.ch6
Adult stem cells in regenerative medicine of endocrine system
Bailey, A. J., Bolandnazar, N. S., Najafzadeh, M., Zafar, M. S., Saeinasab, M., & Sefat, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34152-6.00012-3
Karimi, A., Shiri, Z., Tabrizi, R., Naderi, S., Salahi, S., Elmi, M., & Baharvand, H. (2025) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x374086250602050549
Dopaminergic-Induced Pluripotent Stem Cells for Parkinson’s Disease
Boehringer, A. V., & Kordower, J. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_13
Tunable population diversity through a noise-driven differentiation switchPreprint
Jiang, J., Chen, S., Park, J., Tsou, T., Yang, V., Rivaud, P., & Thomson, M. W. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.20.677552
Cell Therapy for Parkinson’s Disease with Pluripotent Stem Cells
Morizane, A. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_10
Self-citationGenome Editing and Human-Induced Pluripotent Stem Cells Facilitate Parkinson’s Disease Modeling
Polanco, C. M., Inzunza, J., Nalvarte, I., & Arias, J. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_3
Towards the establishment of treatments for neurodegenerative diseases using human iPSCs
Inoue, H. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.103132
Self-citationCharacterization of the intraspecies chimeric mouse brain at embryonic day 12.5
Strell, P., Waldron, M. A., Johnson, S. T., Shetty, A. V., Crane, A. T., You, Y., Steer, C. J., & Low, W. C. (2025) · Cell Transplantation · doi:10.1177/09636897251384571
“Dopamine precursor cells from human fetal brain and iPSC-derived cells were shown to engraft and ameliorate movement disorders in PD patients 14,17–21 .”
Cell Biology: Creating Structure and Function
Boulis, N. M., Lakhina, Y., & Kara, R. H. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009597852.013
Nisat, U. T., Dutta, M., Ullah, M. H., & Khandaker, M. U. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27414-5.00004-x
Modelling forward-programmed megakaryocyte culture for manufacturing process development
Cheeseman, E. (2019) · Loughborough University Research Repository (Loughborough University) · doi:10.26174/thesis.lboro.10695329
Hua, Y., Yoshimochi, K., Li, J., Takekita, K., Shimotsuma, M., Li, L., Qu, X., Zhang, J., Sawa, Y., Liu, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20001144
Hua, Y., Yoshimochi, K., Li, J., Takekita, K., Shimotsuma, M., Li, L., Qu, X., Zhang, J., Sawa, Y., Liu, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20001147
Liang, L., Tian, Y., Feng, L., Wang, C., Feng, G., Stacey, G. N., Shyh‐Chang, N., Wu, J., Hu, B., Li, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20486797
THE USE OF STEM CELLS IN NEUROLOGY
Przerwa, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4515
Mustafa, M. A., Al-Hasnaawei, S., Kaur, I., H., M., Maharana, L., Dhyani, A., Chauhan, A. S., Sharma, J., & Nathiya, D. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08719-1
“Numerous research labs transplant progenitor cells that are still in an immature developmental stage [23–26].”
Factors influencing efficacy of neural stem and progenitor cell transplantation
Baltazar, A., & Dulin, J. N. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01140
“This resulted in a reduced immune response and an increase in spontaneous movement in the primate models, which was tested using magnetic resonance imaging, positron emission tomography, and video-based analysis (Kikuchi et al., 2017).”
Ariaei, A., Ketabforoush, A. H. M. E., Bordbar, S., Barati, S., Lotfi, A., Sayahpour, F. A., Faghihi, F., & Abediankenari, S. (2026) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-026-00850-8
Jacobs, B., Ivanov, D., Barraza, I., Faulk, C. D., Booth, C. J., Mattos-Canedo, R., Tian, L., DePietro, K., Uzun, A., Roos, W. P., et al. (2026) · Biomolecules · doi:10.3390/biom16030412
Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson’s Disease
Onuigbo, C. C., Martínez-Lemus, J. D., Tharp, E., & Schiess, M. C. (2026) · Cells · doi:10.3390/cells15070578
Dissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Étude de la propagation de l'alpha-synucléine de l'hôte vers le greffon dans la maladie de Parkinson
Patrigeon, M. (2022) · theses.fr (ABES) · doi:10.70675/8d75463az5b67z46bfz8649zc3e016dabdda
Lemarié, L. (2024) · theses.fr (ABES) · doi:10.70675/4b717f02z8fbcz4870z85e7z88b55140b5ec
Yang, X. (2026) · Precision Medical Sciences · doi:10.1002/prm2.70033
Limitations of Stem Cell Therapy for Parkinson’s Disease
Li, Z., Peng, S., Jia, O. Y., & Liu, R. (2026) · Cells · doi:10.3390/cells15090839
“However, the ability of human pluripotent stem cell (hPSC)-derived neurons to extend axons far enough to re-innervate the human brain has been demonstrated in nonhuman primates by intraspinal transplantation experiments [82,180].”
Investigation of Neurotransplantation and Regenerative Therapy in Preclinical Models
Sugaya, K. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_28
Stem Cell Therapy for Parkinson’s Disease: A Mechanistically Distinct Role for Muse Cells
Mesches, M. H., Granholm, A., Paredes, D., Coleman-Mesches, K., Oguma, Y., & Dezawa, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114370
Lineage-selective suicide gene system enables post-engraftment editing of cell therapy compositionPreprint
Jin, J., Pavan, C., Moriarty, N., Ovchinnikov, D. A., Farrell, G., Quattrocchi, A. T., Hunt, C. P., & Parish, C. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.729995
Liu, J. T., Li, D. Y., Wu, S., & Liu, N. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11157-x
“…deficits; these neurons substantially ameliorate symptoms such as bradykinesia and muscular rigidity by efficiently stimulating neuronal activity [35, 36]. iPSC-derived natural killer (NK) cells display phenotypic and functional characteristics comparable to peripheral blood-derived NK cells and…”
Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer’s disease therapy
Ding, X., Hu, X., Xue, W., An, Y., Cheng, W., Zhang, S., Lei, A., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1820099
“To assess the long-term A b clearance ability of CAR-iMGLs in vivo , tacrolimus was used as an immunosuppressant to mitigate xenogeneic rejection, as it is widely used in allotransplantation (28, 29).”
Astrocytes in Parkinson’s disease: Beyond support, toward therapy
Wu, S., Wang, W., Yang, L., Pan, S., Thomas, E. R., & Li, X. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115964
Adak, R., Kumar, P., Yadav, S. S., Chaudhary, S., & Datusalia, A. K. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.006
Current Challenges and Future Perspectives of iPSC-Derived Cardiomyocytes
Tanaka, N., tsutsui, K., & Senbonmatsu, T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016950
Li, S., Zhao, M., Zhang, S., Yang, R., Zhang, Y., Yin, N., Koziol, M. J., & Faiola, F. (2026) · Journal of Environmental Sciences · doi:10.1016/j.jes.2026.105742
Metadata
- Authors
- Kikuchi, T., Morizane, A., Doi, D., Magotani, H., Onoe, H., Hayashi, T., Mizuma, H., Takara, S., Takahashi, R., Inoue, H., Morita, S., Yamamoto, M., Okita, K., Nakagawa, M., Parmar, M., & Takahashi, J.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Lund University (SE)
- Corresponding author
- Takahashi, Jun
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7669
- Pages
- 592-596
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2751466955
- Cited by
- 702
- References
- 48
- Citations by year
- 2026: 33 · 2025: 53 · 2024: 74 · 2023: 69 · 2022: 91 · 2021: 89 · 2020: 123 · 2019: 88 · 2018: 75 · 2017: 6
- FWCI
- 32.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (15H02502, 15H02540, 16H03306, 15K12779, 16H03300)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, dopaminergic neurons, induced pluripotent stem cells, cell transplantation, nonhuman primate model, Macaca fascicularis, MPTP-induced neurotoxicity, midbrain dopaminergic neurons, spontaneous movement, neurite outgrowth, corin, tumor formation, cell survival, cell tracking, immune response, cell therapy
- MeSH terms
- Adult, Aged, Aged, 80 and over, Animals, Cell Survival, Disease Models, Animal, Humans, Macaca fascicularis, Magnetic Resonance Imaging, Male, Mesencephalon, Movement, Parkinson Disease, Serine Endopeptidases, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurites, Neostriatum, Regenerative Medicine, Cell Proliferation, Positron-Emission Tomography, Induced Pluripotent Stem Cells, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.